These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37307420)

  • 1. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
    Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
    Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
    Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
    Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
    Yarur AJ; Bruss A; Moosreiner A; Beniwal-Patel P; Nunez L; Berens B; Colombel JF; Targan SR; Fox C; Melmed GY; Abreu MT; Deepak P
    Gastroenterology; 2023 Oct; 165(4):963-975.e5. PubMed ID: 37499955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease.
    Harper JW; Sinanan MN; Zisman TL
    Inflamm Bowel Dis; 2013 Sep; 19(10):2118-24. PubMed ID: 23863401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
    Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
    Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
    Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
    Zeng Q; Wang L; Dong S; Zha X; Ran L; Li Y; Chen S; Gao J; Li S; Lu Y; Zhang Y; Xiao X; Li Y; Ma X; Gong X; Chen W; Yang Y; Du X; Chen B; Lv Y; Wu Y; Hong G; Pan Y; Jiao J; Yan Y; Qi H; Zhai J; Li K; Zhao K; Wu J; Liu S; Blake GM; Fu H; Fu X; Guo Z; Lemieux I; Després JP; Cheng X;
    Metabolism; 2021 Feb; 115():154456. PubMed ID: 33259834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
    Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
    Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
    Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
    United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman SN; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.
    Bidulescu A; Liu J; Hickson DA; Hairston KG; Fox ER; Arnett DK; Sumner AE; Taylor HA; Gibbons GH
    BMC Cardiovasc Disord; 2013 Feb; 13():9. PubMed ID: 23433085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease.
    Thiberge C; Charpentier C; Gillibert A; Modzelewski R; Dacher JN; Savoye G; Savoye-Collet C
    J Crohns Colitis; 2018 Nov; 12(12):1429-1437. PubMed ID: 30260374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
    Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
    EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of adult genetic risk scores for adiposity with childhood abdominal, liver and pericardial fat assessed by magnetic resonance imaging.
    Monnereau C; Santos S; van der Lugt A; Jaddoe VWV; Felix JF
    Int J Obes (Lond); 2018 Apr; 42(4):897-904. PubMed ID: 29437161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
    Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
    Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
    Rivers JP; Powell-Wiley TM; Dey AK; Rodante JA; Chung JH; Joshi AA; Natarajan B; Sajja AP; Chaturvedi A; Rana A; Harrington CL; Teague HL; Lockshin BN; Ahlman MA; Yao J; Playford MP; Gelfand JM; Mehta NN
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):349-357. PubMed ID: 29055628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
    Sekine K; Nagata N; Sakamoto K; Arai T; Shimbo T; Shinozaki M; Okubo H; Watanabe K; Imbe K; Mikami S; Nozaki Y; Sakurai T; Yokoi C; Kojima Y; Kobayakawa M; Yanase M; Akiyama J; Noda M; Uemura N
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1325-31. PubMed ID: 25869941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Fukushima T; Maetani T; Chubachi S; Tanabe N; Asakura T; Namkoong H; Tanaka H; Shimada T; Azekawa S; Otake S; Nakagawara K; Watase M; Shiraishi Y; Terai H; Sasaki M; Ueda S; Kato Y; Harada N; Suzuki S; Yoshida S; Tateno H; Yamada Y; Jinzaki M; Hirai T; Okada Y; Koike R; Ishii M; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
    Metabolism; 2024 Jan; 150():155715. PubMed ID: 37918794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.